Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice

A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS

J.T. LITCHFIELD, Frank Wilcoxon · Journal of Pharmacology and Experimental Therapeutics · 1949 · 7.3K citations

Public Health, Biostatistics, Pharmacology +12

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral Ischemia

Malcolm J. Sheardown, Elsebet Ø. Nielsen, Anker Jón Hansen et al. · Science · 1990 · 1.1K citations

Medicine, Neuroscience, Pharmacology +16

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

Sean D. Donevan, Michael A. Rogawski · Neuron · 1993 · 359 citations

Medicine, Neuroscience, Pharmacology +15

Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.

Isao Ito, Shuichi Tanabe, A Kohda et al. · The Journal of Physiology · 1990 · 323 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors

Ladislav Vyklický, Doris K. Patneau, Mark L. Mayer · Neuron · 1991 · 265 citations

Life Sciences, Neuroscience, Pharmacology +14